Rare Disease: 2024 in review
As we reflect on another year in the rare disease space, we are proud of the continued growth and evolution of CRA’s rare disease capabilities and offerings....
Gregory K. Bell
Group Vice President and Life Sciences Practice Leader
Dr. Bell frequently testifies as an expert witness on damages in intellectual property, finance, and antitrust litigation in courts and arbitration proceedings in North America, Europe, Asia, and Australia.
Dr. Bell’s business consulting engagements focus on the economics of business strategy, working with firms to develop sustainable competitive advantages in specific product markets. He has led numerous projects concerning game theory and competitive strategy, global launch strategy, product pricing and positioning, capital budgeting and real options, and cost-benefit analyses.
Dr. Bell also leads CRA’s global Life Sciences practice with a focus on pharmaceuticals, biotech, medtech, devices, diagnostics, and wellness.
Recent achievement
Global Leader - Arbitration Expert Witnesses 2022
Who's Who Legal
Credentials
Get In Touch
Gregory K. Bell